The US has launched a Section 301 investigation into Germany concerning alleged underpayment for innovative pharmaceuticals, potentially impacting US commerce. Germany's proposed healthcare reforms and fast-tracking of legislation to reduce drug spending are key concerns.
Cyber extortion group FulcrumSec claims to have stolen over 1TB of sensitive data from Novo Nordisk, including source code, drug information, and clinical trial data. The group allegedly demanded $25 million, which Novo Nordisk reportedly refused to pay. FulcrumSec is now reportedly exploring selling the stolen data.
Europe's pharmaceutical sector faces decline due to geopolitical instability and lack of domestic support, falling behind the US and China in innovation, R&D, and clinical trials. Urgent action is needed to rebuild its ecosystem.
Breckenridge Pharmaceuticals thu hồi gần 370.000 lọ thuốc Duloxetine do tạp chất N-nitroso-duloxetine có thể gây ung thư. FDA xếp loại thu hồi là Nhóm II, ảnh hưởng tạm thời hoặc có thể khắc phục về y tế.
Australian pharmaceutical group Sigma Healthcare has dropped its $10bn pursuit of UK retail chain Boots, stating the deal would not meet its strategic and capital investment objectives. The withdrawal extends uncertainty for the 177-year-old chain, which was put up for sale in 2022. Sigma shares rose 6% on the news.
Taiwanese entrepreneur Lai Caida shared his entrepreneurial journey at the 18th Straits Forum in Xiamen, aiming to become the "SpaceX of the pharmaceutical industry" with his AI-powered drug delivery platform, Jitaikeji. The company, which started in Hangzhou, has now listed in Hong Kong and Lai invited other Taiwanese youth to pursue opportunities in mainland China.
Beijing's Zhongguancun Life Science Park is a hub for pharmaceutical and health industry innovation, leveraging AI for drug discovery and offering shared labs and R&D platforms. It supports startups with resources and funding, contributing to significant industry growth and the development of groundbreaking medicines.
Several South Korean companies, including Pyeongjeon Pharmaceutical, SeAH Steel, and others, have announced significant financial activities such as capital increases and stock acquisitions totaling billions of won. The Korea Association of Listed Companies will also hold a meeting for its members.
Australia's One Nation party faces scrutiny over 'sloppy' financial reports with over $1m in missing assets. US President Trump accuses Iran of 'playing us for suckers' amid imminent strike threats. Thousands of Australian women face medicine uncertainty, while World Cup predictions begin.
The US Department of Defense added WuXi AppTec to its list of Chinese military companies. Analysts predict minimal impact on the company and the broader pharma sector due to cost efficiencies and ongoing collaboration.
Trade turnover between Russia and Uzbekistan surged by nearly 30% in the first quarter of this year, following a 12% increase last year to $11.5 billion. Joint projects span industry, energy, transport, and agriculture.
India and Venezuela are expanding cooperation, especially in energy, with Venezuela becoming India's third-largest crude oil supplier. Discussions aim for a structured energy partnership, covering upstream and downstream sectors, leveraging Venezuela's vast oil reserves and India's growing demand.
Participants at SPIEF-2026 believe Russia can succeed in the global pharmaceutical market by integrating AI, modern tech platforms, and regulatory/financial support. A key challenge identified is creating guaranteed demand for new drugs to attract investment.
Eli Lilly, now the world's largest pharma company, is aggressively pursuing acquisitions, spending over $10 billion on eight deals this year compared to $4 billion last year. Driven by its weight loss drug success, the company is shifting from early-stage bets to more experimental, higher-priced drugs.
Latvian Prime Minister Andris Kulbergs plans to sever trade ties with Russia, though he admits exceptions will be necessary for certain industries like pharmaceuticals. His government was approved on May 8.
US-China geopolitical tensions may extend to biotechnology as Chinese firms secure record $60B in cross-border deals in Q1 2026, dominating global biotech deal-making. US policymakers express concern over capital fueling China's industry growth.
Biomagistral, a Brazilian compounding pharmacy network, is expanding internationally with a model integrating human and veterinary services. The company plans to open branches in Argentina, Spain, and Colombia, leveraging trends in personalized medicine and pet care.
Russia's Economic Development Minister Maxim Reshetnikov stated readiness to enhance agricultural cooperation with Brazil, focusing on increased imports of coffee, fruits, and meat, and collaboration in plant breeding and education. Russia also seeks dialogue on drug registration with Brazil's health agency.
Italy's Ministry of Enterprises and Made in Italy will issue a stamp honoring Giuliani for its over 130-year contribution to the nation's pharmaceutical, industrial, and entrepreneurial history.
Dongkook Pharmaceutical has launched 'My Fit V Liposome Multivitamin Mineral', containing vitamins and minerals. Samjin Pharmaceutical will produce 'Lorazepam Injection', a national essential drug, amid supply concerns. Dong-A Pharmaceutical released a new ad for 'Noscana Gel' featuring Wonhee of girl group ILLIT.
Two thousand Jain manuscripts collected by British pharmaceutical entrepreneur Sir Henry Wellcome are being returned to the Jain community after being held by the Wellcome Collection in London. The collection, spanning the 15th to 19th centuries, will be transferred to the University of Birmingham.
Jiangsu Hengrui Pharmaceutical, China’s largest drug company by market capitalisation, has signed a global collaboration and licensing agreement with US pharmaceutical giant Bristol Myers Squibb (BMS) worth up to US$15.2 billion. Hengrui’s Hong Kong-traded shares climbed 5.3 per cent to HK$69.55 on Tuesday, while its Shenzhen stock rose 4.84 per cent to 56.11 yuan. The deal adds credibility to China’s growing reputation for innovative drug development. Industry players, however, said the country...
The outbreak of Hantavirus on a cruise ship has led to biotech and pharmaceutical stocks surging on reports of firms developing vaccines.
The outbreak of Hantavirus on a cruise ship has led to biotech and pharmaceutical stocks surging on reports of firms developing vaccines.
